Literature DB >> 706423

Survival after mastectomy for breast cancer: predictive value of lymphocyte count and its change after mastectomy in patients with metastases to one to three axillary nodes.

K K Meyer.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 706423     DOI： 10.1007/bf01561511

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  20 in total

1.  Lymphocyte subpopulations in mammary cancer after radiotherapy.

Authors:  J M Anderson; J B Campbell; S E Wood; J E Boyd; F Kelly
Journal:  Clin Oncol       Date:  1975-09

2.  Immune globulins A and M: biologic predictors of recurrence after mastectomy and irradiation.

Authors:  K K Meyer
Journal:  Bull Soc Int Chir       Date:  1975

3.  Peripheral blood lymphocyte counts and survival in breast cancer.

Authors:  J Fodor
Journal:  Neoplasma       Date:  1976       Impact factor: 2.575

Review 4.  Tumor progression and homeostasis.

Authors:  R T Prehn
Journal:  Adv Cancer Res       Date:  1976       Impact factor: 6.242

5.  Peripheral lymphocyte counts in breast carcinoma. An index of immune competence.

Authors:  A E Papatestas; A E Kark
Journal:  Cancer       Date:  1974-12       Impact factor: 6.860

6.  Reduced lymphocyte transformation in breast cancer.

Authors:  M G Whittaker; K Rees; C G Clark
Journal:  Lancet       Date:  1971-05-01       Impact factor: 79.321

7.  Peripheral lymphocyte counts and results of therapeutic castration for advanced mammary cancer.

Authors:  J E Holt; Y T Lee
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

8.  Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils.

Authors:  A Riesco
Journal:  Cancer       Date:  1970-01       Impact factor: 6.860

9.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

10.  Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma.

Authors:  A Yu; H Watts; N Jaffe; R Parkman
Journal:  N Engl J Med       Date:  1977-07-21       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.